Literature DB >> 10320668

Nitric oxide and mitochondrial respiration.

G C Brown1.   

Abstract

Nitric oxide (NO) and its derivative peroxynitrite (ONOO-) inhibit mitochondrial respiration by distinct mechanisms. Low (nanomolar) concentrations of NO specifically inhibit cytochrome oxidase in competition with oxygen, and this inhibition is fully reversible when NO is removed. Higher concentrations of NO can inhibit the other respiratory chain complexes, probably by nitrosylating or oxidising protein thiols and removing iron from the iron-sulphur centres. Peroxynitrite causes irreversible inhibition of mitochondrial respiration and damage to a variety of mitochondrial components via oxidising reactions. Thus peroxynitrite inhibits or damages mitochondrial complexes I, II, IV and V, aconitase, creatine kinase, the mitochondrial membrane, mitochondrial DNA, superoxide dismutase, and induces mitochondrial swelling, depolarisation, calcium release and permeability transition. The NO inhibition of cytochrome oxidase may be involved in the physiological regulation of respiration rate, as indicated by the finding that isolated cells producing NO can regulate cellular respiration by this means, and the finding that inhibition of NO synthase in vivo causes a stimulation of tissue and whole body oxygen consumption. The recent finding that mitochondria may contain a NO synthase and can produce significant amounts of NO to regulate their own respiration also suggests this regulation may be important for physiological regulation of energy metabolism. However, definitive evidence that NO regulation of mitochondrial respiration occurs in vivo is still missing, and interpretation is complicated by the fact that NO appears to affect tissue respiration by cGMP-dependent mechanisms. The NO inhibition of cytochrome oxidase may also be involved in the cytotoxicity of NO, and may cause increased oxygen radical production by mitochondria, which may in turn lead to the generation of peroxynitrite. Mitochondrial damage by peroxynitrite may mediate the cytotoxicity of NO, and may be involved in a variety of pathologies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320668     DOI: 10.1016/s0005-2728(99)00025-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  140 in total

Review 1.  New concepts in vascular nitric oxide signaling.

Authors:  R A Oeckler; M S Wolin
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

Review 2.  Role of nitric oxide in the regulation of substrate metabolism in heart failure.

Authors:  Fabio A Recchia
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 3.  Nitric oxide, cell death, and heart failure.

Authors:  Jun-ichi Oyama; Stefan Frantz; Charles Blais; Ralph A Kelly; Todd Bourcier
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

4.  Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

Authors:  Satya Prakash Gupta; Suman Patel; Sharawan Yadav; Anand Kumar Singh; Seema Singh; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

5.  L-arginyl-3,4-spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission.

Authors:  Barclay Morrison; Ashley K Pringle; Terence McManus; John Ellard; Mark Bradley; Francesco Signorelli; Fausto Iannotti; Lars E Sundstrom
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

6.  Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool.

Authors:  Benoît Chénais; Hamid Morjani; Jean-Claude Drapier
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

7.  Nitric oxide at a low concentration protects murine macrophage RAW264 cells against nitric oxide-induced death via cGMP signaling pathway.

Authors:  Y Yoshioka; A Yamamuro; S Maeda
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

8.  Inhibition of nitric oxide synthase by L-NAME speeds phase II pulmonary .VO2 kinetics in the transition to moderate-intensity exercise in man.

Authors:  Andrew M Jones; Daryl P Wilkerson; Katrien Koppo; Sally Wilmshurst; Iain T Campbell
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

Review 9.  Mitochondrial trafficking in neurons: a key variable in neurodegeneration?

Authors:  Ian J Reynolds; Latha M Malaiyandi; Marcy Coash; Gordon L Rintoul
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

10.  Outer-sphere oxidation of Fe(II) in nitrosylmyoglobin by ferricyanide.

Authors:  Jens K S Møller; Leif H Skibsted
Journal:  J Biol Inorg Chem       Date:  2014-02-13       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.